文献速递产科

单球囊导管联合阴道米索前列醇是引产最有效的策略:一项网状Meta分析的Meta综述

Single-balloon catheter with concomitant vaginal misoprostol is the most effective strategy for labor induction: a meta-review with network meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2023-07-16

该Meta综述纳入11篇系统综述、207项随机对照试验共40854名参与者,采用频率随机效应网状Meta分析比较药物、机械及联合引产方法的疗效与安全性。结果显示单球囊导管联合米索前列醇在降低剖宫产和24小时内未阴道分娩的 odds 上最有效(SUCRA均为0.9),并与新生儿重症监护病房入住减少相关。

要点

  • 单球囊导管联合米索前列醇在降低剖宫产和延长至阴道分娩时间上排名最高(SUCRA均为0.9)。
  • 药物中低剂量阴道米索前列醇降低剖宫产最有效,高剂量阴道米索前列醇实现24小时内阴道分娩最有效(SUCRA均为0.9)。
  • 单球囊导管(SUCRA 0.8)和双球囊导管(SUCRA 0.9)分别降低器械阴道分娩和高刺激的 odds 最有效。

核心结论

  • 单球囊导管联合米索前列醇是降低剖宫产 odds 和缩短至阴道分娩时间的最有效方法,并与新生儿重症监护病房入住减少相关。

研究设计与样本

  • 研究为Meta综述与网状Meta分析,检索PubMed、EMBASE和Cochrane对照试验中心注册库自建库至2021年5月31日的文献。
  • 纳入比较住院引产不同药物或方法的随机对照试验的系统综述和Meta分析,最终纳入11篇系统综述,提取207项随机对照试验共40854名参与者的数据。
  • 采用频率随机效应网状Meta分析,并直接配对比较各引产药物与安慰剂或无治疗,用累积排名曲线下面积(SUCRA)排名。

主要发现

  • 单球囊导管联合米索前列醇在降低剖宫产和阴道分娩>24小时的 odds 上最有效,SUCRA均为0.9。
  • 低剂量阴道米索前列醇降低剖宫产 odds 最有效,高剂量阴道米索前列醇实现24小时内阴道分娩最有效,SUCRA均为0.9。
  • 单球囊导管(SUCRA 0.8)和双球囊导管(SUCRA 0.9)分别降低器械阴道分娩和高刺激的 odds 最有效。
  • 颊含或舌下米索前列醇(SUCRA 0.9)及单球囊导管联合米索前列醇(SUCRA 0.9)最有效降低异常Apgar评分和新生儿重症监护病房入住的 odds。

临床怎么用

  • 作者结论认为单球囊导管联合米索前列醇是降低剖宫产 odds 和缩短至阴道分娩时间的最有效方法,并与新生儿重症监护病房入住减少相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Several systematic reviews and meta-analyses have been conducted to summarize the evidence for the efficacy of various labor induction agents. However, the most effective agents or strategies have not been conclusively determined. We aimed to perform a meta-review and network meta-analysis of published systematic reviews to determine the efficacy and safety of currently employed pharmacologic, mechanical, and combined methods of labor induction. DATA SOURCES: With the assistance of an experienced medical librarian, we performed a systematic search of the literature using PubMed, EMBASE, and the Cochrane Central Register of Control Trials. We systematically searched electronic databases from inception to May 31, 2021. STUDY ELIGIBILITY CRITERIA: We considered systematic reviews and meta-analyses of randomized controlled trials comparing different agents or methods for inpatient labor induction. METHODS: We conducted a frequentist random-effects network meta-analysis employing data from randomized controlled trials of published systematic reviews. We performed direct pairwise meta-analyses to compare the efficacy of the various labor induction agents and placebo or no treatment. We performed ranking to determine the best treatment using the surface under the cumulative ranking curve. The main outcomes assessed were cesarean delivery, vaginal delivery within 24 hours, operative vaginal delivery, hyperstimulation, neonatal intensive care unit admissions, and Apgar scores of <7 at 5 minutes of birth. RESULTS: We included 11 systematic reviews and extracted data from 207 randomized controlled trials with a total of 40,854 participants. When assessing the efficacy of all agents and methods, the combination of a single-balloon catheter with misoprostol was the most effective in reducing the odds of cesarean delivery and vaginal birth >24 hours (surface under the cumulative ranking curve of 0.9 for each). Among the pharmacologic agents, low-dose vaginal misoprostol was the most effective in reducing the odds of cesarean delivery, whereas high-dose vaginal misoprostol was the most effective in achieving vaginal delivery within 24 hours (surface under the cumulative ranking curve of 0.9 for each). Single-balloon catheter (surface under the cumulative ranking curve of 0.8) and double-balloon catheter (surface under the cumulative ranking curve of 0.9) were the most effective in reducing the odds of operative vaginal delivery and hyperstimulation. Buccal or sublingual misoprostol (surface under the cumulative ranking curve of 0.9) and the combination of single-balloon catheter and misoprostol (surface under the cumulative ranking curve of 0.9) most effectively reduced the odds of abnormal Apgar scores and neonatal intensive care unit admissions. CONCLUSION: The combination of a single-balloon catheter with misoprostol was the most effective method in reducing the odds for cesarean delivery and prolonged time to vaginal delivery. This method was associated with a reduction in admissions to the neonatal intensive care unit.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sanchez-Ramos L, Lin L, Vilchez-Lagos G, et al. Single-balloon catheter with concomitant vaginal misoprostol is the most effective strategy for labor induction: a meta-review with network meta-analysis. Am J Obstet Gynecol. 2023. PMID: 38462253. doi:10.1016/j.ajog.2022.01.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。